ZIOPHARM Oncology Inc (ZIOP)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

ONE FIRST AVENUE BOSTON, MA 02129

ZIOPHARM Oncology, Inc. is a biopharmaceutical company seeking to acquire, develop and commercialize a diverse, risk-sensitive portfolio of in-licensed cancer drugs that address unmet medical needs. The Company is conducting U.S. studies for its two product candidates, ZIO-101 and ZIO-201.

Data based on most recent fiscal year report
Market Cap807.394 Million Shares Outstanding181.03 Million Avg Volume2.286 Million
1-Yr BETA vs S&P TR1.343 Current Ratio8.89 Quick Ratio8.89
View SEC Filings from ZIOP instead.

View recent insider trading info

Funds Holding ZIOP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ZIOP BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

224.3 Thousand total shares from 6 transactions

Exercise Derivative Conversion (M)

44.6 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ABERCROMBIE GEORGE B CHIEF EXECUTIVE OFFICER

138,424 2020-02-14 0

BOWDEN CHRISTOPHER CHIEF MEDICAL OFFICER

  • Officer
3,581 2020-02-14 3

KIRK RANDAL J

  • 10% Owner
14,231,447 2020-02-13 0

LAFOND KEVIN G SVP, TREASURER & CAO

  • Officer
81,985 2020-01-29 3

COOPER LAURENCE JAMES NEIL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,904,973 2020-01-29 2

MAUNEY DAVID M MD PRESIDENT

  • Officer
275,778 2020-01-29 2

HADFIELD ROBERT GENERAL COUNSEL AND SECRETARY

  • Officer
159,819 2020-01-29 2

DE GROOT ELEANOR EVP, GM CELL THERAPY

  • Officer
228,033 2020-01-29 3

BUCK JILL EVP, GM GENE THERAPY

  • Officer
227,410 2020-01-29 3

SHUKLA SATH EVP, CHIEF FINANCIAL OFFICER

  • Officer
80,500 2020-01-29 3

TARRIFF SCOTT CEO

  • Officer
  • Director
  • 10% Owner
1,550,954 2020-01-23 1

SCHWARTZ BRIAN SEE REMARKS

  • Officer
0 2020-01-16 0

BRAUNSTEIN SCOTT

  • Director
26,500 2020-01-09 1

AMELLO JASON

  • Director
0 2020-01-02 0

EZICKSON ELAN

  • Director
71,887 2019-12-31 1

PAGAN DOUGLAS W.

  • Director
35,943 2019-12-31 1

HAGEN HEIDI

  • Director
32,119 2019-12-31 3

KIRK RANDAL J

INTREXON CORP

  • 10% Owner
0 2019-12-13 0

LEBEL FRANCOIS CHIEF MEDICAL OFFICER

  • Officer
115,155 2019-11-06 0

WEISER MICHAEL

  • Director
0 2019-06-10 0

FOWLER WYCHE

  • Director
77,233 2019-05-22 0

CANNON JAMES ANTHONY

  • Director
398,050 2019-05-07 1

BELBEL CAESAR J COO, CLO, AND SECRETARY

  • Officer
207,434 2017-12-29 0

BRENNAN MURRAY

  • Director
72,620 2017-12-29 0

MCINERNEY TIMOTHY

  • Director
0 2017-05-18 0

YOUSSOUFIAN HAGOP CHIEF MEDICAL OFFICER

  • Officer
0 2015-03-07 0

LEWIS JONATHAN CEO

  • Officer
  • Director
744,145 2014-12-30 0

BAGLEY RICHARD E PRESIDENT, COO & TREASURER

  • Officer
  • Director
211,239 2011-12-30 0

FRAGIN GARY S

  • Director
67,500 2010-03-31 0

ESSEX WOODLANDS HEALTH VENTURES FUND VI L P

  • 10% Owner
2,371,642 2009-09-15 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

HADFIELD ROBERT - Officer GENERAL COUNSEL AND SECRETARY

2020-01-29 A 59,100 a 159,819 159,819.00 direct

LAFOND KEVIN G - Officer SVP, TREASURER & CAO

2020-01-29 A 18,000 a 81,985 81,985.00 direct

SHUKLA SATH - Officer EVP, CHIEF FINANCIAL OFFICER

2020-01-29 A 123,900 a 123,900 80,500.00 direct

COOPER LAURENCE JAMES NEIL - Director - Officer CHIEF EXECUTIVE OFFICER

2020-01-29 A 171,700 a 1,904,973 1,904,973.00 direct

BUCK JILL - Officer EVP, GM GENE THERAPY

2020-01-29 A 82,600 a 82,600 227,410.00 direct

MAUNEY DAVID M MD - Officer PRESIDENT

2020-01-29 A 123,900 a 123,900 275,778.00 direct

SHUKLA SATH - Officer EVP, CHIEF FINANCIAL OFFICER

2020-01-29 A 80,500 a 80,500 80,500.00 direct

DE GROOT ELEANOR - Officer EVP, GM CELL THERAPY

2020-01-29 A 82,600 a 82,600 228,033.00 direct

HADFIELD ROBERT - Officer GENERAL COUNSEL AND SECRETARY

2020-01-29 A 90,800 a 90,800 159,819.00 direct

BUCK JILL - Officer EVP, GM GENE THERAPY

2020-01-29 A 53,700 a 227,410 227,410.00 direct

MAUNEY DAVID M MD - Officer PRESIDENT

2020-01-29 A 80,500 a 275,778 275,778.00 direct

COOPER LAURENCE JAMES NEIL - Director - Officer CHIEF EXECUTIVE OFFICER

2020-01-29 A 264,200 a 264,200 1,904,973.00 direct

DE GROOT ELEANOR - Officer EVP, GM CELL THERAPY

2020-01-29 A 53,700 a 228,033 228,033.00 direct

MAUNEY DAVID M MD - Officer PRESIDENT

2020-01-02 S 22,394 $4.55 d 195,278 195,278.00 direct yes

BUCK JILL - Officer EVP, GM GENE THERAPY

2020-01-02 S 27,923 $4.55 d 173,710 173,710.00 direct yes

LAFOND KEVIN G - Officer SVP, TREASURER & CAO

2020-01-02 S 21,570 $4.55 d 63,985 63,985.00 direct yes

HADFIELD ROBERT - Officer GENERAL COUNSEL AND SECRETARY

2020-01-02 S 16,853 $4.55 d 100,719 100,719.00 direct yes

DE GROOT ELEANOR - Officer EVP, GM CELL THERAPY

2020-01-02 S 24,890 $4.55 d 174,333 174,333.00 direct yes

EZICKSON ELAN - Director

2019-12-31 F 40,107 $4.72 d 71,887 71,887.00 direct

LAFOND KEVIN G - Officer SVP, TREASURER & CAO

2019-12-31 A 48,000 a 48,000 63,985.00 direct

PAGAN DOUGLAS W. - Director

2019-12-31 F 20,054 $4.72 d 35,943 35,943.00 direct

HAGEN HEIDI - Director

2019-12-31 A 31,780 a 32,119 32,119.00 direct

EZICKSON ELAN - Director

2019-12-31 A 31,780 a 111,994 71,887.00 direct

BRAUNSTEIN SCOTT - Director

2019-12-31 A 31,780 a 31,780 31,780.00 direct

PAGAN DOUGLAS W. - Director

2019-12-31 A 15,890 a 55,997 35,943.00 direct

BOWDEN CHRISTOPHER - Director

2019-12-31 A 50,562 a 50,562 0.00 direct

PAGAN DOUGLAS W. - Director

2019-12-31 A 25,281 a 25,281 35,943.00 direct

TARRIFF SCOTT - Director

2019-12-31 A 50,562 a 50,562 0.00 direct

COOPER LAURENCE JAMES NEIL - Director - Officer CHIEF EXECUTIVE OFFICER

2019-12-30 S 110,694 $4.88 d 1,733,273 1,733,273.00 direct yes

COOPER LAURENCE JAMES NEIL - Director - Officer CHIEF EXECUTIVE OFFICER

2019-12-27 M 44,642 $2.24 a 1,843,967 1,733,273.00 direct

COOPER LAURENCE JAMES NEIL - Director - Officer CHIEF EXECUTIVE OFFICER

2019-12-27 M 44,642 d 487,171 1,733,273.00 direct

Elevate your investments